MVA Pharma SRL
3.4 FTEMVA Pharma reported total assets of 621,644 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Jul 2026), with 3.4 full-time equivalents.
The score of MVA Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +30 % Total assets -17 % Headcount (avg FTE) +3 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MVA Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 36,057 € | ||||
| Equity | 240,013 € | ||||
| Cash | 66,698 € | ||||
| EBITDA | 107,136 € | ||||
| Total assets | 621,644 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
MVA Pharma's financial analysis
- Solvency38.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MVA Pharma
MVA Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0749.944.612
- VAT number
- BE0749944612
- Peppol
- Registered · 0208:0749944612 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jul 2020
- Registered office
- 6060 Charleroi
- Size
- Micro · 3.4 FTE
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MVA Pharma (SRL) has been based in Charleroi since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,057 € and equity of 240,013 €; its revenue is not published. With 3.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 38.6%, below the median of its sector (41.5%).
Companies similar to MVA Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Charlotte Sulmon Retail sale of pharmaceutical products Zwevegem · balance sheet 621,627 €
- Pharmacie Solvay Retail sale of pharmaceutical products Herstal · balance sheet 621,411 €
- Heldo Retail sale of pharmaceutical products Erpe-Mere · balance sheet 621,357 €
- Zichem Pharma Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 622,406 €
- Pharmadil Retail sale of pharmaceutical products Dilbeek · balance sheet 620,651 €
- Bioclin Retail sale of pharmaceutical products Ostend · balance sheet 623,434 €
- PH DE Linde Retail sale of pharmaceutical products Anderlecht · balance sheet 619,651 €
- Hubert Pellegrin Retail sale of pharmaceutical products Uccle · balance sheet 623,769 €
Frequently asked questions about MVA Pharma
What is the revenue of MVA Pharma?
MVA Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MVA Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0749944612 for MVA Pharma, if the company is VAT-registered. Its company number (CBE) is 0749.944.612.
Where is the registered office of MVA Pharma?
According to the CBE register, the registered office of MVA Pharma is in 6060 Charleroi.
What is the equity of MVA Pharma?
At the close of the 2025 financial year, the equity of MVA Pharma amounts to 240,013 €, a solvency of 38.6% of total assets.
How many people work at MVA Pharma?
3.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages MVA Pharma?
The register lists 2 active mandates at MVA Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MVA Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →